Glonghui November 28 | According to the latest equity disclosure data from the Stock Exchange, on November 24, 2023, Changmao Biotech (00954.HK) received an increase of 196,000 shares in the market by an average price of HK$0.548 per share, involving approximately HK$107,400, by executive director Rui Xinsheng (Chairman).
After increasing its holdings, the latest number of shares held by Rui Xinsheng was 6.228 million shares, and the shareholding ratio increased from 3.28% to 3.39%.
